Larson Financial Group’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-193
Closed -$1.02K – 3884
2026
Q2
$1.02K Sell
193
-148
-43% -$779 ﹤0.01% 3306
2026
Q1
$1.42K Hold
341
– – ﹤0.01% 3063
2025
Q4
$1.64K Hold
341
– – ﹤0.01% 2821
2025
Q3
$1.72K Buy
341
+193
+130% +$853 ﹤0.01% 2762
2025
Q2
$596 Hold
148
– – ﹤0.01% 2811
2025
Q1
$404 Hold
148
– – ﹤0.01% 2628
2024
Q4
$629 Hold
148
– – ﹤0.01% 2142
2024
Q3
$435 Hold
148
– – ﹤0.01% 2161
2024
Q2
$515 Hold
148
– – ﹤0.01% 1833
2024
Q1
$422 Hold
148
– – ﹤0.01% 1573
2023
Q4
$522 Buy
+148
New +$425 ﹤0.01% 1571

Other funds holding SRTA

Larson Financial Group's SRTA Position: Q3 2026 in Review

Larson Financial Group sold out of Strata Critical Medical Inc (SRTA) in Q3 2026, closing a stake of 193 shares — an estimated $1.02K sold.

Larson Financial Group first reported a position in SRTA in Q4 2023 and held it in 11 quarters. The position peaked at $1.72K in Q3 2025. 53 funds tracked by Wall St. Rank hold SRTA as of Q3 2026.

  • Larson Financial Group reported no remaining Strata Critical Medical Inc position as of Q3 2026 after selling out during the quarter.
  • Larson Financial Group sold 193 Strata Critical Medical Inc shares in Q3 2026, an estimated $1.02K.
  • Larson Financial Group first reported a position in Strata Critical Medical Inc in Q4 2023 and held it in 11 quarters.
  • Larson Financial Group's Strata Critical Medical Inc position peaked at $1.72K in Q3 2025.
  • 53 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.